Our Hope—And Questions—About Biogen and Eisai’s Latest Alzheimer’s Drug Trial Results
By
Being Patient
| July 9th, 2018
After years of failure, including some pharmaceutical companies calling off Alzheimer’s research altogether, Biogen offers a glimmer of hope: New data from a Phase…